Recently Funded Post-IPO Equity Biotechnology Startups
Updated Sep 2026
FundedIQ holds 218 funded Post-IPO Equity Biotechnology startups and keeps their funding rounds, amounts, investors, industries, locations and company details up to date. This page provides an overview of the Post-IPO Equity Biotechnology startup funding landscape, along with the 100 most recently funded Post-IPO Equity Biotechnology startups.
Cambridge and San Diego hold the deepest concentrations of these companies.
Biotechnology activity clusters heavily within Cambridge and San Diego. While North American presence dominates, pockets of activity in Israel and Switzerland create a global reach. This concentration means a strategy centered on a few key cities captures the primary weight of the segment, though international outliers remain relevant.
Post-IPO Equity Biotechnology funded startup statistics
Funded Post-IPO Equity Biotechnology startups
218
tracked in the database
Most recent funding round on record: Oct 2022.
100 most recently funded Post-IPO Equity Biotechnology startups
100 of 218Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.
Company
What they do
Latest round
Amount
V
Vaxcyte
Foster City, United States · Biotechnology
Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by…
Post-IPO Equity ·
$600M
T
Thermogenesis
Rancho Cordova, United States · Biotechnology
Post-IPO Equity ·
$2.1M
T
Taysha Gene Therapies
Dallas, United States · Biotechnology
Taysha Gene Therapies is dedicated to eliminating serious and life-threatening genetic diseases in the…
Post-IPO Equity ·
$50M
B
Biohaven Pharmaceutical
New Haven, United States · Biotechnology
Post-IPO Equity ·
$302M
E
Eevia Health
Seinäjoki, Finland · Biotechnology
Eevia Health is a Nordic life science company based in Finland and Norway, with headquarters in Seinäjoki and…
Post-IPO Equity ·
$1.9M
D
Denali Therapeutics
San Francisco, United States · Biotechnology
Post-IPO Equity ·
$275M
C
Charlotte's Web
Denver, United States · Biotechnology
Post-IPO Equity ·
$4.2M
D
Dice Therapeutics
San Francisco, United States · Biotechnology
Post-IPO Equity ·
$345M
C
ChromaDex
Los Angeles, United States · Biotechnology
Post-IPO Equity ·
$3.1M
A
Axcella
Cambridge, United States · Biotechnology
Post-IPO Equity ·
$34M
V
VectivBio
Basel, Switzerland · Biotechnology
VectivBio is a clinical-stage biotechnology organization carrying groundbreaking prescriptions to patients…
Post-IPO Equity ·
$125M
I
immatics biotechnologies
Tübingen, Germany · Biotechnology
immatics is a biopharmaceutical company that is dedicated to identifying effective targets for cancer…
Post-IPO Equity ·
$110M
I
Immunic Therapeutics
New York, United States · Biotechnology
Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies…
Post-IPO Equity ·
$60M
B
Bone Biologics
Burlington, United States · Biotechnology
Bone Biologics, a company headquartered in Burlington, MA, is publicly traded and specializes in the…
Post-IPO Equity ·
$5.1M
I
InVivo Therapeutics
Cambridge, United States · Biotechnology
Post-IPO Equity ·
$9.0M
A
Amylyx Pharmaceuticals
Cambridge, United States · Biotechnology
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.…
Post-IPO Equity ·
$246M
F
First Wave BioPharma
Brooklyn, United States · Biotechnology
First Wave BioPharma is a biopharmaceutical company at the clinical stage that focuses on creating targeted…
Post-IPO Equity ·
$6.0M
N
Neptune Wellness Solutions
Quebec, Canada · Biotechnology
Neptune Wellness Solutions is a wellbeing and health organization centers around extraction, plan, and…
Post-IPO Equity ·
$6.0M
I
Immunovant
New York, United States · Biotechnology
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with…
Post-IPO Equity ·
$75M
X
Xortx Therapeutics
Calgary, Canada · Biotechnology
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat…
Post-IPO Equity ·
$5.0M
N
NLS Pharma
Stans, Switzerland · Biotechnology
NLS Pharma is a company in the clinical stage of drug development that specializes in neurobehavioral and…
Post-IPO Equity ·
$4.0M
R
Rocket Pharmaceuticals
Cranbury, United States · Biotechnology
Post-IPO Equity ·
$100M
A
Anebulo Pharmaceuticals
Austin, United States · Biotechnology
Anebulo is a clinical-stage biotechnology company developing novel solutions for people suffering from…
Post-IPO Equity ·
$6.6M
S
Sonendo
Laguna Hills, United States · Biotechnology
Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The…
Post-IPO Equity ·
$63M
A
Aadi Bioscience
Pacific Palisades, United States · Biotechnology
Aadi Bioscience, Inc. is a biopharmaceutical company developing precision therapies for genetically-defined…
Post-IPO Equity ·
$73M
L
LipUm
Umeå, Sweden · Biotechnology
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
Post-IPO Equity ·
$3.5M
M
MediWound
Yavne, Israel · Biotechnology
MediWound is a biotechnology niche specialty company. Established in 2001, MediWound is focused on…
Post-IPO Equity ·
$30M
S
Spero Therapeutics
Cambridge, United States · Biotechnology
Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections. The…
Post-IPO Equity ·
$9.0M
A
Advanced Enzymes
Thane, India · Biotechnology
Advanced Enzyme is a research driven company manufacturing enzymes and probiotics and dedicated to marketing…
Post-IPO Equity ·
$9.9M
A
Alpine Immune Sciences
Seattle, United States · Biotechnology
Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein-based…
Post-IPO Equity ·
$100M
T
Therapeutic Solutions International
Oceanside, United States · Biotechnology
Therapeutic Solutions International is a biotechnology company engaged in the development of products for…
Post-IPO Equity ·
$10M
A
Aditxt Therapeutics
Loma Linda, United States · Biotechnology
Aditx Therapeutics is a biotechnology company developing a novel nucleic acid-based technology to selectively…
Post-IPO Equity ·
$20M
K
Kuros Biosciences
Schlieren, Switzerland · Biotechnology
Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue…
Post-IPO Equity ·
$6.2M
A
Akero Therapeutics
Cambridge, United States · Biotechnology
Akero Therapeutics is dedicated to providing effective treatment options for individuals suffering from…
Post-IPO Equity ·
$200M
I
IDEAYA Biosciences
South San Francisco, United States · Biotechnology
IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of…
Post-IPO Equity ·
$80M
L
Larimar Therapeutics
Bala Cynwyd, United States · Biotechnology
Larimar Therapeutics, Inc. is a biotechnology company in the clinical stage that is dedicated to creating…
Post-IPO Equity ·
$70M
S
Sarepta Therapeutics
Cambridge, United States · Biotechnology
Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of…
Post-IPO Equity ·
$6.0M
E
Edgewise Therapeutics
Boulder, United States · Biotechnology
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and…
Post-IPO Equity ·
$138M
I
Imugene
Sydney, Australia · Biotechnology
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
Post-IPO Equity ·
$54M
A
Akari Therapeutics
London, United Kingdom · Biotechnology
Akari is a biopharmaceutical company focused on developing inhibitors of acute and chronic inflammation,…
Post-IPO Equity ·
$13M
B
Benitec Ltd
Hayward, United States · Biotechnology
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and…
Post-IPO Equity ·
$18M
C
Codiak Biosciences
San Francisco, United States · Biotechnology
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based…
Post-IPO Equity ·
$20M
R
Relay Therapeutics
Cambridge, United States · Biotechnology
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational…
Post-IPO Equity ·
$300M
I
InMed Pharmaceuticals
Vancouver, Canada · Biotechnology
A leader in the creation, production, and marketing of rare cannabinoids is InMed Pharmaceuticals. We have…
Post-IPO Equity ·
$6.0M
N
NovaBay Pharmaceuticals
Emeryville, United States · Biotechnology
Going Beyond Antibiotics® Developing Anti-Infective Compounds Effective Against Bacteria, Viruses and Fungi.…
Post-IPO Equity ·
$5.3M
S
SpringWorks Therapeutics
Stamford, United States · Biotechnology
SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to…
Post-IPO Equity ·
$225M
A
Abivax
Paris, France · Biotechnology
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
Post-IPO Equity ·
$49M
K
Kymera Therapeutics
Cambridge, United States · Biotechnology
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.…
Post-IPO Equity ·
$150M
M
Mydecine Innovations Group
Vancouver, Canada · Biotechnology
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental…
Post-IPO Equity ·
$250k
A
Algernon Pharmaceuticals
Delta, Canada · Biotechnology
Breathtec Biomedicala medical diagnostics company focused on developing, in-licensing, and commercializing…
Post-IPO Equity ·
$1.4M
A
Athersys
Cleveland, United States · Biotechnology
A clinical-stage biopharmaceutical business called Athersys has a growing pipeline of potentially…
Post-IPO Equity ·
$12M
F
Frequency Therapeutics
Woburn, United States · Biotechnology
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to…
Post-IPO Equity ·
Undisclosed
F
Fulcrum Therapeutics
Cambridge, United States · Biotechnology
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare…
Post-IPO Equity ·
$75M
H
Handa Pharmaceuticals
Fremont, United States · Biotechnology
Handa Pharmaceuticals, LLC (“Handa”) is a specialty pharmaceutical company established in the San Francisco…
Post-IPO Equity ·
Undisclosed
P
Palisade Bio
Carlsbad, United States · Biotechnology
Palisade Bio is a biopharmaceutical company in the clinical stage that focuses on creating treatments for…
Post-IPO Equity ·
$14M
C
CinCor Pharma
Cincinnati, United States · Biotechnology
CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates…
Post-IPO Equity ·
$225M
I
IN8Bio
New York, United States · Biotechnology
IN8bio is a clinical-stage biopharmaceutical company focused on the discovery, development and…
Post-IPO Equity ·
$10M
K
Karuna Therapeutics
Boston, United States · Biotechnology
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative…
Post-IPO Equity ·
$750M
O
OrthoPediatrics
Warsaw, United States · Biotechnology
OrthoPediactrics is a medical device company that develops and manufactures orthopedic implants and…
Post-IPO Equity ·
$125M
H
Heron Therapeutics
Redwood City, United States · Biotechnology
Heron Therapeutics is a specialized pharmaceutical company creating drug products with the help of its…
Post-IPO Equity ·
$77M
M
Medicenna Therapeutics
Toronto, Canada · Biotechnology
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Post-IPO Equity ·
$20M
M
Mirum Pharmaceuticals
San Diego, United States · Biotechnology
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of…
Post-IPO Equity ·
$92M
P
Poxel
Lyon, France · Biotechnology
Poxel is an innovative biopharmaceutical company that focuses on developing medications for metabolic…
Post-IPO Equity ·
$6.1M
H
Helius Medical Technologies
Newtown, United States · Biotechnology
Helius Medical Technologies is a company specializing in neurotechnology that aims to enhance neurological…
Post-IPO Equity ·
$18M
A
Applied DNA Sciences
Stony Brook, United States · Biotechnology
Applied DNA Sciences provides DNA solutions designed to provide the highest level of security. From marking…
Post-IPO Equity ·
$12M
P
Poseida Therapeutics
San Diego, United States · Biotechnology
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities…
Post-IPO Equity ·
$70M
A
Apexigen
Burlingame, United States · Biotechnology
Apexigen is a biopharmaceutical product development company advancing a pipeline of novel product candidates…
Post-IPO Equity ·
$15M
F
Fennec Pharmaceuticals
Durham, United States · Biotechnology
Fennec Pharmaceuticals Inc. (TSX: FRX, OTC: Interim ADHXD, Final FENCF (October 2, 2014), is a clinical-stage…
Post-IPO Equity ·
$45M
T
Trevena
King Of Prussia, United States · Biotechnology
Trevena is a privately owned biopharmaceutical company based in King of Prussia, PA, focused on developing…
Post-IPO Equity ·
$2.0M
V
VolitionRx
Singapore, Singapore · Biotechnology
Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…
Post-IPO Equity ·
$6.0M
L
Lexicon Pharmaceuticals
The Woodlands, United States · Biotechnology
Vocabulary Pharmaceuticals, Inc. (previously Lexicon Genetic) a biopharmaceutical organization, centers…
Post-IPO Equity ·
$43M
A
AlloVir
Houston, United States · Biotechnology
AlloVir centers around the advancement of cell treatments and spotlights on reestablishing regular resistance…
Post-IPO Equity ·
$127M
L
Legend Biotech
Piscataway, United States · Biotechnology
Legend Biotech is a biopharmaceutical organization getting effective developments cell treatment, and…
Post-IPO Equity ·
$250M
A
Addex Therapeutics
Plan-les-ouates, Switzerland · Biotechnology
Addex Therapeutics is a clinical-stage drug organization zeroed in on the turn of events and…
Post-IPO Equity ·
$4.2M
K
Kiora Pharmaceuticals
Salt Lake City, United States · Biotechnology
Kiora is a clinical-stage specialty drug organization creating and commercializing items for treating…
Post-IPO Equity ·
$6.0M
O
Organicell Regenerative Medicine
Miami, United States · Biotechnology
Organicell Regenerative Medicine is an exosome therapeutics organization with an emphasis on growing new…
Post-IPO Equity ·
$4.0M
R
Revolution Medicines
Redwood City, United States · Biotechnology
Revolution Medicines is developing new therapies through an innovative approach that harnesses the complex…
Post-IPO Equity ·
$265M
A
ANGLE
Guildford, United Kingdom · Biotechnology
Point is a financially determined expert clinical symptomatic organization with spearheading items in…
Post-IPO Equity ·
$24M
G
Gossamer Bio
San Diego, United States · Biotechnology
Gossamer Bio is a San Diego-put together organization centered with respect to the revelation and improvement…
Post-IPO Equity ·
$120M
A
Applied Genetics Technologies Corporation
Alachua, United States · Biotechnology
Applied Genetics Technologies Corporation (AGTC) is creating treatments intended to change the existences of…
Post-IPO Equity ·
$10M
P
Pliant Therapeutics
South San Francisco, United States · Biotechnology
Malleable Therapeutics is a clinical stage biopharmaceutical organization zeroed in on finding and creating…
Post-IPO Equity ·
$200M
A
Annexon Biosciences
South San Francisco, United States · Biotechnology
Annexon is a clinical-stage biopharmaceutical organization fostering a pipeline of novel treatments for…
Post-IPO Equity ·
$130M
E
ESSA Pharma
Vancouver, Canada · Biotechnology
ESSA is a drug organization zeroed in on the improvement of little particle drugs for the therapy of…
Post-IPO Equity ·
$14M
N
Nurix Therapeutics
San Francisco, United States · Biotechnology
Nurix Therapeutics is a biopharmaceutical organization zeroed in on the revelation, improvement, and…
Post-IPO Equity ·
$40M
P
Provention Bio
Red Bank, United States · Biotechnology
A clinical-stage biopharmaceutical business called Provention Bio is committed to finding, creating, and…
Post-IPO Equity ·
$60M
S
Syros Pharmaceuticals
Watertown, United States · Biotechnology
Syros Pharmaceuticals is a daily existence sciences organization that is centered around treating infection…
Post-IPO Equity ·
$130M
A
Agile Therapeutics
Princeton, United States · Biotechnology
Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's…
Post-IPO Equity ·
$24M
H
Hofseth BioCare
Ålesund, Norway · Biotechnology
Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through…
Post-IPO Equity ·
$14M
B
Biolase
Irvine, United States · Biotechnology
Dental specialists and dentists can execute a variety of minimally invasive dental operations with the use of…
Post-IPO Equity ·
$6.5M
B
BioSig Technologies
Westport, United States · Biotechnology
At BioSig, we're working to develop and deliver the advanced signal processing solutions that will unlock the…
Post-IPO Equity ·
$3.5M
T
Tonix Pharmaceuticals
New York, United States · Biotechnology
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and…
Post-IPO Equity ·
$30M
X
Xenon Pharmaceuticals
Burnaby, Canada · Biotechnology
Xenon Pharmaceuticals is a biopharmaceutical organization zeroed in on the improvement of novel drugs through…
Post-IPO Equity ·
$288M
C
Cantargia
Lund, Sweden · Biotechnology
The company's foundation lies in the initial finding that leukemic stem cells in individuals with chronic…
Post-IPO Equity ·
$25M
P
Precision BioSciences
Durham, United States · Biotechnology
Accuracy BioSciences is a biotechnology organization committed to further developing lives through its…
Post-IPO Equity ·
$50M
T
Trajan
Ringwood, Australia · Biotechnology
Trajan is a biotech organization that creates and markets innovations that empower logical frameworks.
Post-IPO Equity ·
$21M
A
Arcellx
Gaithersburg, United States · Biotechnology
Arcellx is a clinical-stage biotechnology organization reconsidering cell treatment by designing inventive…
Post-IPO Equity ·
$112M
A
Atrys Health
Barcelona, Spain · Biotechnology
ATRYS is an imaginative biomedical organization devoted to the arrangement of particular demonstrative…
Post-IPO Equity ·
$76M
D
Day One Biopharmaceuticals
South San Francisco, United States · Biotechnology
The very first moment Biopharmaceuticals is a biotechnology organization that spotlights on growing new…
Post-IPO Equity ·
$173M
C
Cogent Biosciences
Cambridge, United States · Biotechnology
Pertinent Biosciences utilizes restrictive T-cell designing innovation in blend with growth focusing on…
Post-IPO Equity ·
$150M
D
DBV Technologies
Bagneux, France · Biotechnology
DBV Technologies is a worldwide clinical stage biopharmaceutical organization established by pediatricians…
Post-IPO Equity ·
$192M
118 more funded startups
218 startups · 100 visible
Unlock with FundedIQ
This page shows the 100 most recent rounds (back to Jun 2022). The full 218-company history for this listing opens on a FundedIQ plan.
Company
Location
Round
Amount
Unlock all 218 companies in this listing: full funding history, investors, and founders.
Post-IPO Equity Biotechnology startup funding trends
Company size
The most common headcount band across the segment is 11-50.
Countries with the most funded Post-IPO Equity Biotechnology startups
Where funded Post-IPO Equity Biotechnology startups are headquartered, by the country on the company record.
Country
Funded startups
Where are funded Post-IPO Equity Biotechnology startups located?
Where funded Post-IPO Equity Biotechnology startups are based, by the city on the company record.
City
Funded startups
About the FundedIQ Post-IPO Equity Biotechnology startup funding data
FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.
Figures on this page cover the 218 funded Post-IPO Equity Biotechnology startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. The most recent round on record for funded Post-IPO Equity Biotechnology startups is dated Oct 2022.
The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.
Frequently asked questions
How many funded Post-IPO Equity Biotechnology startups are there?
FundedIQ tracks 218 funded Post-IPO Equity Biotechnology startups. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.
Which countries have the most funded Post-IPO Equity Biotechnology startups?
United States leads with 154 companies, ahead of Canada (15), Israel (7) and Switzerland (7).
Which cities have the most funded Post-IPO Equity Biotechnology startups?
Cambridge leads with 14 companies, then San Diego (12), New York (10) and San Francisco (7).
How often is the Post-IPO Equity Biotechnology startup funding data updated?
The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Post-IPO Equity Biotechnology startups is dated Oct 2022. Counts and totals on this page are recomputed on every refresh.
Related listings
14-day free trial · Cancel anytime
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.